Stay updated with breaking news from Paulj hastings. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) Director Paul J. Hastings sold 880 shares of the stock in a transaction that occurred on Thursday, June 13th. The shares were sold at an average price of $28.38, for a total transaction of $24,974.40. Following the sale, the director now directly owns 12,724 shares of the […] ....
Nkarta, Inc. (NASDAQ:NKTX – Get Free Report) fell 5.7% on Tuesday . The stock traded as low as $10.11 and last traded at $10.20. 68,322 shares were traded during trading, a decline of 97% from the average session volume of 2,093,983 shares. The stock had previously closed at $10.82. Wall Street Analysts Forecast Growth NKTX […] ....
Nkarta, Inc. (NASDAQ:NKTX – Free Report) – Investment analysts at HC Wainwright boosted their Q1 2024 earnings per share estimates for shares of Nkarta in a report released on Monday, March 25th. HC Wainwright analyst E. Bodnar now expects that the company will post earnings per share of ($0.46) for the quarter, up from their […] ....
Nkarta (NASDAQ:NKTX) PT Raised to $16.00 at Canaccord Genuity Group themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Nkarta, Inc. (NASDAQ:NKTX – Get Free Report) gapped down prior to trading on Thursday . The stock had previously closed at $11.09, but opened at $10.80. Nkarta shares last traded at $10.82, with a volume of 70,617 shares trading hands. Analyst Upgrades and Downgrades Several analysts recently weighed in on the stock. Mizuho reduced their […] ....